Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation
- PMID: 325728
Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation
Similar articles
-
Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients.Transplant Proc. 1978 Jun;10(2):463-6. Transplant Proc. 1978. PMID: 354136 No abstract available.
-
Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).Transplant Proc. 1979 Jun;11(2):1429-30. Transplant Proc. 1979. PMID: 382531 No abstract available.
-
Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.Surgery. 1976 Aug;80(2):155-63. Surgery. 1976. PMID: 781887 Clinical Trial.
-
Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.Transplant Proc. 1974 Dec;6(4 Suppl 1):67-70. Transplant Proc. 1974. PMID: 4612906 Review. No abstract available.
-
Genetics and mode of presentation of antigenic determinants: influence on immunologic responsiveness in transplantation.Hum Immunol. 1982 Apr;4(2):157-66. doi: 10.1016/0198-8859(82)90015-5. Hum Immunol. 1982. PMID: 6176573 Review. No abstract available.
Cited by
-
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2. Cochrane Database Syst Rev. 2017. PMID: 28073178 Free PMC article.